Southern California Wildfires – American Academy of Ophthalmology
Resources regarding recent devastation caused by wildfires
Related Articles
Temperature Excursion of Intravitreal Anti-VEGF Agents During Home Storage
This quality improvement study assesses patient adherence to temperature guidelines for home storage of anti–vascular endothelial growth factor (anti-VEGF) agents in France.
Image Sharing: Making Interoperability a Reality
The promise of interoperability for image sharing, and why you should insist that your vendors comply with DICOM standards.
Caught Between a Rock and a Hard Place: Comanagement of Neovascular AMD and Geographic Atrophy
In 2023, two complement inhibitors (CIs) were approved by the FDA for the treatment of geographic atrophy (GA), an advanced form of age-related macular de…
RhyGaze secures Series A financing of $86 million to further novel gene therapy
The funding will support activities like formal pharmacology and toxicology testing.
Regeneron Acquires Oxular
Conexiant Vision: Delivering trusted clinical content, deep audience engagement, and educational resources for eye care professionals. Discover more through our magazines, newsletters, and events.
Three-Year Results of the MOSAIC Randomized Clinical Trial
This secondary analysis of the 3-year results of the 24-Month Myopia Outcome Study of Atropine in Children (MOSAIC) randomized clinical trial investigates the efficacy and…
Ashvattha Therapeutics secures $50M in financing to advance clinical trials
The new funding will allow the company to complete its ongoing Phase 2 trial of proprietary nanomedicine, migaldendranib, in patients with wet AMD and DME
Samsara Vision announces positive intermediate-term visual and safety outcomes of SING IMT 6 months post-surgery
Ophthalmology Times – ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.
Ocugen announces positive 2-year safety and efficacy update of Phase 1/2 OCU400 for treatment of retinitis pigmentosa
OCU400 demonstrated meaningful improvement of 2-line gain (10 letters on ETDRS chart) in low-luminance visual acuity (LLVA) in treated eyes when compared to untreated fellow…